Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Clinical management of localized colon cancer with capecitabine.

Quidde J, Arnold D, Stein A.

Clin Med Insights Oncol. 2012;6:363-73. doi: 10.4137/CMO.S8194. Epub 2012 Nov 5.

2.

The clinical and cost-effectiveness of oxaliplatin and capecitabine for the adjuvant treatment of colon cancer: systematic review and economic evaluation.

Pandor A, Eggington S, Paisley S, Tappenden P, Sutcliffe P.

Health Technol Assess. 2006 Nov;10(41):iii-iv, xi-xiv, 1-185. Review.

3.

Capecitabine: a review.

Walko CM, Lindley C.

Clin Ther. 2005 Jan;27(1):23-44. Review.

PMID:
15763604
4.

Adjuvant therapy for early colon cancer: current status.

Stein A, Hiemer S, Schmoll HJ.

Drugs. 2011 Dec 3;71(17):2257-75. doi: 10.2165/11594490-000000000-00000. Review.

PMID:
22085384
5.

Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database.

McCleary NJ, Meyerhardt JA, Green E, Yothers G, de Gramont A, Van Cutsem E, O'Connell M, Twelves CJ, Saltz LB, Haller DG, Sargent DJ.

J Clin Oncol. 2013 Jul 10;31(20):2600-6. doi: 10.1200/JCO.2013.49.6638. Epub 2013 Jun 3.

6.

[Oral capecitabine as postoperative adjuvant chemotherapy in stage III colon cancer patients].

Yamaguchi T, Fukuda M, Yasui H, Okazaki S, Kubo K, Tanaka M, Une Y, Setoguchi Y, Hanada K, Moriyama S, Tani M, Murakami T, Okuchi Y, Ogiso S, Hata H, Sakata S, Otani T, Yamato T, Ikai I.

Gan To Kagaku Ryoho. 2012 Mar;39(3):389-93. Japanese.

PMID:
22421765
7.

Capecitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal carcinoma.

Twelves C, Boyer M, Findlay M, Cassidy J, Weitzel C, Barker C, Osterwalder B, Jamieson C, Hieke K; Xeloda Colorectal Cancer Study Group.

Eur J Cancer. 2001 Mar;37(5):597-604.

PMID:
11290435
8.

Toxicity profile and efficacy of oral capecitabine as adjuvant chemotherapy for Chinese patients with Stage III colon cancer.

Law CC, Fu YT, Chau KK, Choy TS, So PF, Wong KH.

Dis Colon Rectum. 2007 Dec;50(12):2180-7.

PMID:
17963003
9.

Redefining adjuvant chemotherapy in patients with stage III colon cancer: X-ACT trial.

Glen H, Cassidy J.

Expert Rev Anticancer Ther. 2008 Apr;8(4):547-51. doi: 10.1586/14737140.8.4.547.

PMID:
18402521
10.
11.

A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):282-308. Review.

PMID:
11441937
12.

Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.

Van Cutsem E, Twelves C, Cassidy J, Allman D, Bajetta E, Boyer M, Bugat R, Findlay M, Frings S, Jahn M, McKendrick J, Osterwalder B, Perez-Manga G, Rosso R, Rougier P, Schmiegel WH, Seitz JF, Thompson P, Vieitez JM, Weitzel C, Harper P; Xeloda Colorectal Cancer Study Group.

J Clin Oncol. 2001 Nov 1;19(21):4097-106.

PMID:
11689577
13.

Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial.

Scheithauer W, McKendrick J, Begbie S, Borner M, Burns WI, Burris HA, Cassidy J, Jodrell D, Koralewski P, Levine EL, Marschner N, Maroun J, Garcia-Alfonso P, Tujakowski J, Van Hazel G, Wong A, Zaluski J, Twelves C; X-ACT Study Group.

Ann Oncol. 2003 Dec;14(12):1735-43.

PMID:
14630678
14.

The role of levamisole in the adjuvant treatment of stage III colon cancer patients: a randomized trial of 5-fluorouracil and levamisole versus 5-fluorouracil alone.

Cascinu S, Catalano V, Piga A, Mattioli R, Marcellini M, Pancotti A, Bascioni R, Torresi U, Silva RR, Pieroni V, Giorgi F, Catalano G, Cellerino R.

Cancer Invest. 2003;21(5):701-7.

PMID:
14628428
15.
16.

Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis.

Sanoff HK, Carpenter WR, Freburger J, Li L, Chen K, Zullig LL, Goldberg RM, Schymura MJ, Schrag D.

Cancer. 2012 Sep 1;118(17):4309-20. doi: 10.1002/cncr.27422. Epub 2012 Jan 31.

17.
18.

Oral capecitabine: bridging the Atlantic divide in colon cancer treatment.

Van Cutsem E, Verslype C, Tejpar S.

Semin Oncol. 2005 Feb;32(1):43-51. Review.

PMID:
15726505
19.

Capecitabine as adjuvant treatment for stage III colon cancer.

Twelves C, Wong A, Nowacki MP, Abt M, Burris H 3rd, Carrato A, Cassidy J, Cervantes A, Fagerberg J, Georgoulias V, Husseini F, Jodrell D, Koralewski P, Kröning H, Maroun J, Marschner N, McKendrick J, Pawlicki M, Rosso R, Schüller J, Seitz JF, Stabuc B, Tujakowski J, Van Hazel G, Zaluski J, Scheithauer W.

N Engl J Med. 2005 Jun 30;352(26):2696-704.

20.

Supplemental Content

Support Center